Biogen, Inc. (BIIB)
218.50
-3.00
(-1.35%)
USD |
NASDAQ |
Aug 28, 16:00
218.18
-0.32
(-0.15%)
After-Hours: 20:00
Biogen Cash from Operations (Annual) : 2.205B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.205B |
| December 31, 2024 | 2.876B |
| December 31, 2023 | 1.547B |
| December 31, 2022 | 1.384B |
| December 31, 2021 | 3.640B |
| December 31, 2020 | 4.230B |
| December 31, 2019 | 7.079B |
| December 31, 2018 | 6.188B |
| December 31, 2017 | 4.551B |
| December 31, 2016 | 4.522B |
| December 31, 2015 | 3.716B |
| December 31, 2014 | 2.942B |
| December 31, 2013 | 2.345B |
| December 31, 2012 | 1.880B |
| December 31, 2011 | 1.728B |
| December 31, 2010 | 1.625B |
| December 31, 2009 | 1.075B |
| December 31, 2008 | 1.564B |
| Date | Value |
|---|---|
| December 31, 2007 | 1.021B |
| December 31, 2006 | 841.27M |
| December 31, 2005 | 889.50M |
| December 31, 2004 | 727.99M |
| December 31, 2003 | 219.21M |
| December 31, 2002 | 179.22M |
| December 31, 2001 | 153.81M |
| December 31, 2000 | 61.98M |
| December 31, 1999 | 52.50M |
| December 31, 1998 | 5.087M |
| December 31, 1997 | -2.759M |
| December 31, 1996 | -4.142M |
| December 31, 1995 | -2.589M |
| December 31, 1994 | -19.14M |
| December 31, 1993 | -4.721M |
| December 31, 1992 | -6.609M |
| December 31, 1991 | -6.175M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ionis Pharmaceuticals, Inc. | -268.58M |
| AbbVie, Inc. | 19.03B |
| Regeneron Pharmaceuticals, Inc. | 4.979B |
| Vertex Pharmaceuticals, Inc. | 3.631B |
| Amgen, Inc. | 9.958B |